[Molecular therapy for vascular disease using an oligonucleotide-based strategy].
Miyake
Takashi
T
miyake@cgt.med.osaka-u.ac.jp
Morishita
Ryuichi
R
D000783:Aneurysm / Q000628:therapy; D052157:Aptamers, Nucleotide; D015316:Genetic Therapy / Q000379:methods*; D006083:Graft Occlusion, Vascular / Q000517:prevention & control; D006801:Humans; D016328:NF-kappa B; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use*; D034741:RNA, Small Interfering / Q000627:therapeutic use*; D014652:Vascular Diseases / Q000209:etiology / Q000628:therapy*
D052157:Aptamers, Nucleotide; D016328:NF-kappa B; D016376:Oligonucleotides, Antisense; D034741:RNA, Small Interfering